Transferred At Point In Time was iBio’s largest revenue line in fiscal 2020, bringing in $1.49M of $1.64M (91%).
| Timing of Transfer of Good or Service | FY 2019 | FY 2020 |
|---|---|---|
| Transferred Over Time | — | $147.00K |
| Recognized Over Time | $1.85M | — |
| Transferred At Point In Time | — | $1.49M |
| Recognized At A Point In Time | $170.00K | — |
| Total | $2.02M | $1.64M |
iBio brought in $1.64M from its two revenue lines in fiscal 2020, the year ended June 30, 2020. iBio regrouped these revenue lines after fiscal 2019, so the total does not compare directly with that year's $2.02M. Transferred At Point In Time was the largest at $1.49M (91.0%), ahead of Transferred Over Time at $147.00K (9.0%).
iBio began breaking out Transferred Over Time in fiscal 2020 and Transferred At Point In Time in fiscal 2020. iBio stopped reporting Recognized Over Time ($1.85M in fiscal 2019) and Recognized At A Point In Time ($170.00K in fiscal 2019) as separate revenue lines.
iBio (IBIO) reports its revenue by timing of transfer of good or service. In fiscal 2020, Transferred At Point In Time was its largest revenue line, bringing in $1.49M (91.0% of the total), followed by Transferred Over Time at $147.00K (9.0%).
Transferred At Point In Time was iBio's largest revenue line in fiscal 2020, bringing in $1.49M, or 91.0% of the $1.64M total across its two revenue lines.
Every figure comes from iBio's annual financial filings, as reported. Each line keeps the name iBio gives it, and years follow its fiscal calendar.
iBio's revenue by timing of transfer of good or service goes back to fiscal 2019, with figures through fiscal 2020. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.